Plant ID: NPO228
Plant Latin Name: Physostigma venenosum
Taxonomy Genus: Physostigma
Taxonomy Family: Fabaceae
NCBI TaxonomyDB:
271807
Plant-of-the-World-Online:
n.a.
India; Jordan; China
GPR35; | |
OPRD1; | |
BCHE; ACHE; | |
BLM; AMY1A;AMY1B;AMY1C; GFER; | |
PTPRS; | |
PIM1; KIT; GRK6; | |
TP53; | |
LMNA; NPC1; RAB9A; | |
SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Enzyme_unclassified | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Enzyme_unclassified | AMY1A;AMY1B;AMY1C | Salivary alpha-amylase | P04745 | CHEMBL2478 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Hydrolase | BCHE | Butyrylcholinesterase | P06276 | CHEMBL1914 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Peptide receptor (family A GPCR) | OPRD1 | Delta opioid receptor | P41143 | CHEMBL236 |
Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Protein Kinase | KIT | Stem cell growth factor receptor | P10721 | CHEMBL1936 |
Protein Kinase | GRK6 | G protein-coupled receptor kinase 6 | P43250 | CHEMBL6144 |
Protein Phosphatase | PTPRS | Receptor-type tyrosine-protein phosphatase S | Q13332 | CHEMBL2396508 |
Small molecule receptor (family A GPCR) | GPR35 | G-protein coupled receptor 35 | Q9HC97 | CHEMBL1293267 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Unclassified | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004556; alpha-amylase activity | 1.280E-08 | 1.394E-04 | AMY1A, AMY1B, AMY1C |
MF | Unclassified; | GO:0103025; alpha-amylase activity (releasing maltohexaose) | 1.280E-08 | 1.394E-04 | AMY1A, AMY1B, AMY1C |
MF | GO:0003824; catalytic activity | GO:0003990; acetylcholinesterase activity | 1.238E-06 | 6.741E-03 | ACHE, BCHE |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.238E-06 | 9.745E-03 | CYP1A1, CYP1B1, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 7.754E-06 | 2.111E-02 | BCHE, CYP1A1, CYP1B1, CYP2D6 |
BP | GO:0050896; response to stimulus | GO:0010035; response to inorganic substance | 9.765E-06 | 2.363E-02 | BLM, CYP1A1, CYP1B1, KIT, NPC1, TP53 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.764E-05 | 3.841E-02 | CYP1A1, CYP1B1, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009820; alkaloid metabolic process | 2.591E-05 | 4.031E-02 | BCHE, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 2.591E-05 | 4.031E-02 | CYP1A1, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 3.063E-05 | 4.447E-02 | CYP1A1, CYP1B1, CYP2D6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00500 | Starch and sucrose metabolism | 3.083E-05 | 1.095E-03 | AMY1A, AMY1B, AMY1C |
09150 Organismal Systems | 09154 Digestive system | hsa04973 | Carbohydrate digestion and absorption | 1.591E-05 | 1.095E-03 | AMY1A, AMY1B, AMY1C |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 6.835E-05 | 1.618E-03 | CYP2D6, CYP1A1, CYP1B1 |
09150 Organismal Systems | 09154 Digestive system | hsa04970 | Salivary secretion | 1.234E-04 | 2.190E-03 | AMY1A, AMY1B, AMY1C |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 8.784E-04 | 1.247E-02 | CYP1A1, CYP1B1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04913 | Ovarian steroidogenesis | 1.370E-03 | 1.622E-02 | CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 1.777E-03 | 1.632E-02 | KIT, PIM1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 2.446E-03 | 1.929E-02 | KIT, TP53 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.839E-03 | 1.632E-02 | CYP1A1, CYP1B1 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 3.637E-03 | 2.582E-02 | CYP1A1, CYP1B1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Epileptic seizures | G40, P90, R56 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | ACHE; |
N00-N99: Diseases of the genitourinary system | Urinary dysfunction | N39.3-N39.4 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | ACHE; |
C00-D49: Neoplasms | Cancer | C00-C96 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE; |
NA: NA | Upper abdominal bloating | NA | ACHE; |
H00-H59: Diseases of the eye and adnexa | Chronic glaucoma | H40-H42 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Migraine | G43 | CYP2D6; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis diagnosis | G70.0 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poison intoxication | T36-T50 | ACHE; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Poisoning due to pesticides and chemicals | T36-T50 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mild cognitive impairment | F06.7 | ACHE; |
NA: NA | Early satiation associated with functional dyspepsia | NA | ACHE; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | ACHE; |
K00-K95: Diseases of the digestive system | Xerostomia | K11.7, R68.2 | ACHE; |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Pain | G64, G90.0, R52, G89 | ACHE; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | ACHE; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CYP2D6; |
G00-G99: Diseases of the nervous system G00-G99 | Myasthenia gravis | G70.0 | ACHE; |